Treat and Reduce Obesity Act

Summary

  • First Introduced: 2013
  • Latest Action: Re-introduced as “Treat and Reduce Obesity Act of 2017” on April 5, 2017 (view the full legislation)

Key Points

The nation is paying the price for overlooking the importance of food and nutrition. We are an increasingly overweight and obese nation, with two-thirds of the adult population carrying excess weight. Obesity is an astronomically expensive problem for our nation ($210 billion per year). The Treat and Reduce Obesity Act offers clinically- and cost-effective solutions to the obesity epidemic.

Clinically Effective

  • The bill removes unnecessary barriers to (1) allow a variety of qualified practitioners, such as RDNs, to effectively treat obesity through IBT and authorize coverage for FDA-approved weight loss medications that complement IBT.
  • Research shows that after two years, patients who received IBT from a RDN are twice as likely to achieve clinically significant weight loss, experience greater average weight loss, and exercise more than patients who did not receive IBT.
  • The expert consensus is that RDNs are the best practitioners to carry out IBT, as stated by the IOM, U.S. Preventive Services Task Force and most physicians.

Cost Effective

  • Supporting RDNs to provide IBT is cost effective.
  • RDNs' services cost 25-percent less per 2 pounds of weight loss.
  • RDNs' payment fee is 85 percent of primary care providers' fees.
  • RDNs can help minimize costs for nutrition services, like IBT, while delivering the best results.
  • The bill provides coordinated, interdisciplinary care that increases efficiency and efficacy, which improves health care quality and reduces costs.

Download the Academy’s Treat and Reduce Obesity Act 2017 issue brief and leave behind for information about the re-introduction the legislation in 2017.